Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cartesian Therapeutics (RNAC) Total Current Liabilities: 2015-2025

Historic Total Current Liabilities for Cartesian Therapeutics (RNAC) over the last 10 years, with Sep 2025 value amounting to $13.8 million.

  • Cartesian Therapeutics' Total Current Liabilities fell 35.52% to $13.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $13.8 million, marking a year-over-year decrease of 35.52%. This contributed to the annual value of $23.0 million for FY2024, which is 66.32% down from last year.
  • Latest data reveals that Cartesian Therapeutics reported Total Current Liabilities of $13.8 million as of Q3 2025, which was up 12.62% from $12.3 million recorded in Q2 2025.
  • Cartesian Therapeutics' 5-year Total Current Liabilities high stood at $95.6 million for Q3 2021, and its period low was $12.3 million during Q2 2025.
  • In the last 3 years, Cartesian Therapeutics' Total Current Liabilities had a median value of $23.0 million in 2024 and averaged $26.6 million.
  • As far as peak fluctuations go, Cartesian Therapeutics' Total Current Liabilities skyrocketed by 287.81% in 2021, and later slumped by 75.18% in 2022.
  • Cartesian Therapeutics' Total Current Liabilities (Quarterly) stood at $72.3 million in 2021, then tumbled by 65.29% to $25.1 million in 2022, then soared by 172.00% to $68.2 million in 2023, then plummeted by 66.32% to $23.0 million in 2024, then slumped by 35.52% to $13.8 million in 2025.
  • Its Total Current Liabilities was $13.8 million in Q3 2025, compared to $12.3 million in Q2 2025 and $15.0 million in Q1 2025.